ArticleFrontiers in immunology2022

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer.

Rui Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.